Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2025 Jun;12(3):2239-2244.
doi: 10.1002/ehf2.15248. Epub 2025 Feb 26.

Secondary sclerosing cholangitis in patients suffering cardiogenic shock

Affiliations
Multicenter Study

Secondary sclerosing cholangitis in patients suffering cardiogenic shock

Hugo Lanz et al. ESC Heart Fail. 2025 Jun.

Abstract

Aims: Cardiogenic shock (CS) patients suffer from severe organ hypoperfusion, yet the incidence of secondary sclerosing cholangitis in critically ill patients (SSC-CIP) in CS is poorly described. Given the limited evidence and severity of this syndrome, we aimed to further investigate SSC-CIP in the context of CS.

Methods and results: 24 251 total CS patients admitted between 1 January 2010 and 31 December 2023 were retrospectively screened for the diagnosis of SSC-CIP across nine German tertiary care centers. Following identification of confirmed SSC-CIP diagnosis, baseline characteristics, laboratory values, SSC-CIP-specific imaging, diagnostics, and outcomes were obtained for analysis. 35 CS patients with a diagnosis of SSC-CIP were identified, representing a prevalence of 0.14% [95% confidence interval (CI) 0.10, 0.19]. Patients were predominantly male (77.1%) with a median age of 58 years (interquartile range [IQR] 52.5, 68.0). Acute myocardial infarction (42.9%) was the most common aetiology of CS, followed by cardiac arrhythmias (20.0%). Endoscopic retrograde cholangiopancreatography (ERCP) was performed in 77.1% of cases after a median of 33 days following CS onset [IQR 24, 65], showing typical biliary casts (60.0%), intraductal filling defects (28.6%), and bile duct obliteration (20.0%). Cast removal and stent placement was performed in nearly half of ERCP procedures (45.7%). Magnetic resonance cholangiopancreatography (MRCP) was performed in 22.9% of cases and showed intraductal dilation (11.4%), lumen narrowing (17.1%), or strictures (14.3%). Median intensive care unit and hospital length of stay was 43 days [IQR 33, 66] and 58 days [IQR 33, 88], respectively. In-hospital mortality was 57.1%. One-year (65.7%) and 3-year (71.4%) mortality remained high. Two patients underwent liver transplantation after a median of 113 days [IQR 105, 122] and were alive at 3-year follow-up.

Conclusions: In this multicentre retrospective analysis in a high-risk CS cohort, SSC-CIP was a rare yet serious complication of intensive care unit stay with high in-hospital mortality. Treatment options are limited, and liver transplantation remains the only viable long-term treatment option.

Keywords: Cardiogenic shock; Hepatic dysfunction; Secondary sclerosing cholangitis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Jung C, Fuernau G, Eitel I, Desch S, Schuler G, Kelm M, et al. Incidence, laboratory detection and prognostic relevance of hypoxic hepatitis in cardiogenic shock. Clin Res Cardiol 2017;106:341‐349. doi:10.1007/s00392-016-1060-3 - DOI - PubMed
    1. Weig T, Schubert MI, Gruener N, Dolch ME, Frey L, Miller J, et al. Abdominal obesity and prolonged prone positioning increase risk of developing sclerosing cholangitis in critically ill patients with influenza A‐associated ARDS. Eur J Med Res 2012;17:30. doi:10.1186/2047-783X-17-30 - DOI - PMC - PubMed
    1. Ben‐Ari Z, Levingston D, Weitzman E, Haviv‐Yadid Y, Cohen‐Ezra O, Weiss P, et al. Secondary sclerosing cholangitis following major burn. Ann Hepatol 2015;14:695‐701. doi:10.1016/S1665-2681(19)30764-1 - DOI - PubMed
    1. Voigtländer T, Negm AA, Schneider AS, Strassburg CP, Manns MP, Wedemeyer J, et al. Secondary sclerosing cholangitis in critically ill patients: model of end‐stage liver disease score and renal function predict outcome. Endoscopy 2012;44:1055‐1058. doi:10.1055/s-0032-1325733 - DOI - PubMed
    1. Leonhardt S, Veltzke‐Schlieker W, Adler A, Schott E, Hetzer R, Schaffartzik W, et al. Trigger mechanisms of secondary sclerosing cholangitis in critically ill patients. Crit Care 2015;19:131. doi:10.1186/s13054-015-0861-5 - DOI - PMC - PubMed

Publication types

LinkOut - more resources